Adenovirus-Mediated Gene Therapy for Head and Neck Squamous Cell Carcinomas

Abstract

Advanced head and neck squamous cell carcinomas (HNSCCs) have a poor prognosis despite aggressive multimodal therapy. The goal of our study was to test the feasibility of gene transduction as a novel therapy for head and neck cancer. Three human HNSCC cell lines were transduced in vitro with a replication-deficient recombinant adenovirus containing the lacZ marker gene (Ad2/CMVßgal). Gene transduction efficiency was dependent on multiplicity of infection, duration of exposure to the virus, and viral concentration. Next, the HEp-2 cell line was transduced with an adenoviral vector (Ad.RSVtk) containing the herpes simplex virus thymidine kinase (HSVtk) gene, which, when expressed, sensitizes transduced cells to ganciclovir (GCV). Subsequent administration of GCV resulted in complete rumor cell killing. These results suggest that adenovirus-mediated transfer of KSV tk and administration of GCV has potential as a new therapy for HNSCC.

Keywords

adenovirus ganciclovir gene transduction herpes simplex virus thymidine kinase squamous cell carcinoma

Get full access to this article

View all access options for this article.

References

Wingo

Tong

Bolden

. Cancer statistics, 1995. CA Cancer J Clin 1995; 45: 8–30.

Von Hoff

. Head and neck cancer. In: Stein

, ed. Internal medicine. New York, NY: Mosby-Year Book, 1994: 943–7.

Million

Cassisi

Clark

. Cancer of the head and neck. In: Devita

Jr Hellman

Rosenberg

, eds. Cancer, principles and practice of oncology. Philadelphia, Pa: JB Lippincott, 1989: 488–590.

Merino

Lindberg

Fletcher

. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977; 40: 145–51.

Clayman

El-Naggar

Roth

. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995; 55: 1–6.

Vile

Russell

. Gene transfer technologies for the gene therapy of cancer. Gene Ther 1994; 1: 88–98.

Cheng

Grill

Dutschman

Nakayama

Bastow

. Metabolism of 9-(l,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J Biol Chem 1983; 258: 12460–4.

Ram

Culver

Walbridge

Blaese

Oldfield

. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83–8.

DiMaio

Clary

Via

Coveney

Pappas

Lyerly

. Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 1994; 116: 205–13.

10.

Mulligan

. The basic science of gene therapy. Science 1993; 260: 926–32.

11.

Smythe

Hwang

Amin

. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: An effective in vitro drug sensitization system. Cancer Res 1994; 54: 2055–9.

12.

Chen

Shine

Goodman

Woo

. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91: 3054–7.

13.

Shewach

Zerbe

Hughes

Roessler

Breakefield

Davidson

. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther 1994; 1: 107–12.

14.

Simon

Engelhardt

Yang

. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum Gene Ther 1993; 4: 771–80.

15.

Welsh

Smith

Zabner

. Cystic fibrosis gene therapy using an adenovirus vector: In vivo safety and efficacy in nasal epithelium. Hum Gene Ther 1994; 5: 209–19.

16.

Zabner

Couture

Smith

Welsh

. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: Efficiency of adenovirus-mediated gene transfer in vitro. Hum Gene Ther 1994; 5: 585–93.

17.

Rich

Couture

Cardoza

. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 1993; 4: 461–76.

18.

Davidson

Allen

Kozarsky

Wilson

Roessler

. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993; 3: 219–23.

19.

Wan

Parysek

Warnick

Stambrook

. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993; 4: 725–31.

20.

Freeman

Abboud

Whartenby

. The “bystander effect”: Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274–83.

21.

Laskin

Stahl-Bayliss

Kalman

Rosecan

. Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS. J Infect Dis 1987; 155: 323–7.